The Silent Killer: Dr. Angel Lazo Jr. on the New Frontier of Colorectal Cancer Screening

Welcome to Health Frontiers — the show where medical professionals and hospital leaders learn how to bridge the gap between clinical excellence and operational efficiency to save both dollars and lives.In this episode, "The Silent Killer: Dr. Angel Lazo Jr. on the New Frontier of Colorectal Cancer Screening," host Dr. Bob sits down with Dr. Angel Lazo Jr., a board-certified internist and clinical investigator with over 25 years of experience. As March marks Colorectal Cancer Awareness Month, Dr. Lazo shares the alarming shift in the disease’s demographics—including why it is now the leading cause of cancer death for adults under 50—and the revolutionary new tools available to fight it. You’ll hear about the "Shield" blood test, the "Thursday Trap" of missed screenings, and why your family tree matters more than you think.SPONSORED BYThis episode is proudly sponsored by Alpha Hospital Partners LLC, the professional association of Dr. Angel Lazo Jr. Dedicated to clinical excellence, health equity, and the delivery of high-quality care to underserved communities, Alpha Hospital Partners LLC bridges the gap between cellular science and bedside practice.🌐 Visit the website: www.alphahospitalpartnersllc.orgIn this episode, you'll learn:The Under-50 Crisis: Why colorectal cancer has climbed to the #1 spot for cancer deaths in young adults and the tragic reality of late-stage diagnoses in a "preventable" disease.The 54 Million Gap: The staggering statistic that millions of Americans are currently unscreened or late for screening, and why national adherence is stalled at only 56-58%.A "Blood Test" Revolution: Deep dive into "Shield," a new cell-free DNA blood test that uses fragmentomics to detect cancer signals without the "stool-box" fatigue.The Advanced Adenoma Warning: Understanding the morphology and size (greater than 10mm) of polyps that serve as the "check engine light" for your colon.Beer, Smoke, and DNA: How specific lifestyle factors like alcohol consumption and smoking intersect with your family history to create a high-risk profile.The Adherence Problem: Why 3 out of 4 patients refuse to repeat stool-based tests, and how providing "here and now" blood options can bridge the health equity gap.💡 Whether you're a primary care physician looking to improve patient outcomes or a "blue-collar American" worried about taking a day off for a procedure, this episode offers a clear, data-driven roadmap to the most detectable and treatable cancer in medicine.CONTACT + RESOURCES🌐 Website & Contact: https://www.healthfrontierspod.com/🏥 Learn More: Ask your doctor about Shield blood testing or Cologuard Plus if you are between the ages of 45 and 75.📚 Reference: Consult the National Comprehensive Cancer Network (NCCN) guidelines for the latest on category 2A screening options.📲 FOLLOW DR. BOBYouTube: /healthfrontierswithdrbobInstagram: /drboblahitaX (Twitter): @DrLahita📢 If you got value from this episode, subscribe to the channel, leave a review, and share it with someone who is avoiding their screening. Remember: Early detection isn't just a statistic; it's a 91% chance at life. 💥🔖 #HealthFrontiers #ColorectalCancer #ScreeningSavesLives #Colonoscopy #HealthEquity #ShieldTest #DrBob #EarlyDetectionNew Jersey is at 62% screening adherence—what is one thing your local community could do to help us hit the 80% mark?www.healthfrontierspod.com [email protected]